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Abstract
Little is known about factors associated with receipt of medication information among arthritis 
patients. This study explores information source receipt and associations between demographic 
and clinical/patient characteristics and the amount of arthritis medication information patients 
receive. Adult patients with osteoarthritis (OA) or rheumatoid (RA) arthritis (n = 328) completed 
an online cross-sectional survey. Patients reported demographic and clinical/patient characteristics 
and the amount of arthritis medication information received from 15 information sources. 
Bivariate and multivariable linear regression analyses were used to investigate whether those 
characteristics were associated with the amount of medication information patients received. 
Arthritis patients received the most information from health professionals followed by printed 
materials, media sources, and interpersonal sources. Greater receipt of information was associated 
with greater medication adherence, taking more medications, greater medication-taking concerns, 
more satisfaction with doctor medication-related support, and Black compared to White race. RA 
patients reported receiving more information compared to OA patients, and differences were found 
between RA patients and OA patients in characteristics associated with more information receipt. 
In conclusion, arthritis patients received the most medication information from professional 
sources, and both positive (e.g., greater satisfaction with doctor support) and negative (e.g., more 
medication taking concerns) characteristics were associated with receiving more medication 
information.
Since the 1990s, the United States has moved from a paradigm where doctors primarily 
furnished patients with health information to a world in which patients have more 
information sources at their disposal and are more informed and active in self-care roles 
(Fahy, Hardikar, Fox, & Mackay, 2014). Individuals living with arthritis, the most frequent 
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cause of disability among adults in the United States (The Centers for Disease Control and 
Prevention, 2009), represent a group for which quality medication information is particularly 
important as they are likely to experience uncertainty and anxiety when faced with evolving 
treatment options, medication changes, unfamiliar terminology, medication related 
decisions, and adverse medication side effects (Carter, Moles, White, & Chen, 2013b). 
These challenges, coupled with the fact that arthritis patients commonly take multiple 
prescription medications and medication non-adherence for rheumatic disease is a 
substantial problem (Harrold & Andrade, 2009), bring about a specific set of information 
needs related to arthritis. With 52.5 million adults living with arthritis in the United States, 
and numbers projected to increase to 67 million by 2030 (Centers for Disease Control and 
Prevention, 2013), understanding how much medication-related information patients are 
receiving from which sources and what patient factors are associated with information-
receipt is valuable for customizing health communication efforts to this growing 
demographic.
Obtaining arthritis medication-related information can serve important roles in arthritis 
management. It can increase an individual’s health knowledge (e.g., an understanding of 
medication side effects), improve communication with health care providers, increase a 
patient’s coping ability to manage his/her arthritis, and increase long term medication 
treatment adherence (Hay et al., 2008; Niedermann, Fransen, Knols, & Uebelhart, 2004). 
This is important because medication non-adherence and poor persistence can lead to poor 
outcomes such as increased risk of disease flares and disability (Contreras-Yáñez, Ponce De 
León, Cabiedes, Rull-Gabayet, & Pascual-Ramos, 2010). Yet, with the increasing 
availability of health information from various sources (e.g., Internet, medication packet 
inserts) which often varies in content and quality, comes more inconsistency in the accuracy 
of information received by the patient (Ansani et al., 2005; Carpenter, Elstad, Blalock, & 
DeVellis, 2014; Fahy et al., 2014; Impicciatore, Pandolfini, Casella, & Bonati, 1997).
Patients with osteoarthritis (OA) and rheumatoid arthritis (RA), the most prevalent types of 
arthritis (K. Ong, Wu, Cheung, Barter, & Rye, 2013), report multiple reasons for seeking 
health information, with researching treatment or medication options being a main reason 
given, second only to gathering general information about the condition (Hay et al., 2008). 
OA and RA patients report receiving drug related information from multiple information 
sources, including spoken, written, and electronic (Carpenter et al., 2014; DeLorme, Huh, & 
Reid, 2011). The Internet, package inserts, pharmacists, and doctors are the most frequently 
sited sources for prescription drug information with patients reporting doctors as the most 
reliable source (Carpenter et al., 2011; Carpenter et al., 2014; DeLorme et al., 2011; Närhi, 
2007). Further, the largest amount of drug advertising dollars are spent targeting arthritis and 
other common chronic conditions (Findlay, 2001) and there is evidence suggesting more 
advertising is directed at drugs targeting RA compared to OA (Behrman, 2005). We are not 
aware of any studies specifically examining patient or arthritis-specific factors associated 
with arthritis patient receipt of medication information or the extent to which these factors 
are associated with OA compared to RA patients.
When considering factors that may be associated with medication information receipt, it is 
important consider that OA and RA involve different pathophysiologic mechanisms and 
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course progression, yet share similar features (Breedveld & Combe, 2011; Brooks, 2006; 
Carpenter et al., 2015). RA, a systemic autoimmune disease, is generally considered more 
disabling and its medication management more intensive compared to OA (Woolf & Pfleger, 
2003; Yood, 2002). Further, RA patients have more frequent office visits and have higher 
medication costs for drugs such as biologic Disease-Modifying Antirheumatic Drugs 
(DMARDS) compared to OA patients (Lanes et al., 1997). OA can occur in any joint, results 
from factors including mechanical stress and biological processes over time and is mostly 
managed symptomatically with analgesics (e.g., acetaminophen and non-steroidal anti-
inflammatory drugs) and glucosamine sulfate (Laba, Brien, Fransen, & Jan, 2013; Martel-
Pelletier, Boileau, Pelletier, & Roughley, 2008; Woolf & Pfleger, 2003). In spite of the fact 
that RA and OA may be associated with different risk factors and different treatment 
strategies, they both present clinically with pain, stiffness and loss of function, resulting 
from cartilage destruction and joint inflammation (Brooks, 2006; Murphy & Nagase, 2008; 
K. Ong et al., 2013). Additionally, arthritis has been shown to negatively impact both OA 
and RA patients’ health related quality of life, with OA patients perceiving their condition as 
similarly disabling in terms of physical and mental health as RA patients (Geryk, Carpenter, 
Blalock, DeVellis, & Jordan, 2014).
Existing theory and findings from the health information seeking literature offer guidance as 
to which demographic and clinical/patient factors may be related to patients receiving 
medication-related health information. The vast majority of research focuses on 
“information-seeking behavior” (i.e., actively acquiring information), a subset of research 
related to what has been termed “information behavior” or research focusing on how people 
seek information and the channels through which they gain access to information (Wilson, 
1997). The Model of Information Behavior posits that information seeking is motivated by 
an individual’s information needs and intervening variables (e.g., demographic, 
psychological, and interpersonal) (Wilson, 1997). The Risk Perception Attitude Framework 
posits that personal variables such as higher disease related anxiety and higher efficacy 
beliefs (confidence in one’s ability to enact a health behavior) increase a patient’s intentions 
to seek health information (Rimal & Real, 2003). Relatedly, one study found that patients 
accessing irritable bowel syndrome informational websites who report moderate to severe 
impairments in health status reported a willingness to take considerable risk to obtain 
symptom benefit (Drossman et al., 2009).
From the information-seeking literature, we know that demographic variables, such as 
patient age, gender, race, and educational level are related to health information-seeking. For 
example, women, better educated and younger individuals are often reported to seek more 
health information (Bundorf, Wagner, Singer, & Baker, 2006; Hay et al., 2008; Lustria, 
Smith, & Hinnant, 2011; Ramanadhan & Viswanath, 2006; Tu & Cohen, 2008). Among 
individuals with a chronic disease, clinical variables, such as disease type, years living with 
disease, disease severity and comorbidities have the potential to affect information-seeking 
(Ayers & Kronenfeld, 2007; Feinberg, Greenberg, & Frijters, 2015; Fox & Purcell, 2010; 
Wagner, Baker, Bundorf, & Singer, 2004). For example, in a years’ time, individuals with 
hypertension tend to use the internet to obtain health information at lower rates (38%) 
compared to people with cancer (48%) and individuals who report lower health status tend 
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to seek information less compared to those reporting better health (Feinberg et al., 2015; 
Wagner et al., 2004).
That people are seeking medication-related health information and acting on the information 
they find is well established. However, little is known empirically about patient receipt of 
medication-related information, including solicited (e.g., seeking information) and 
unsolicited (e.g., being given information) information from various sources among 
individuals living with arthritis. A deeper understanding of arthritis patient receipt of 
medication related information from various sources and clinical/patient characteristics 
associated with amount of information received are of particular interest because some are 
modifiable and suited to intervention and all may be valuable aims for targeted or tailored 
medication-related communication messages. To understand arthritis patient receipt of 
medication-related information from various sources and associations between clinical/
patient characteristics and receipt of medication information this study addresses the 
following two specific aims: 1) to quantify the amount and describe the sources patients use 
for arthritis medication information and 2) to analyze the relationship between demographic 
and clinical/patient factors and receipt of arthritis medication information.
Methods
Subjects
All data were derived from Information Networks for Osteoarthritis Resources and 
Medications (INFORM) study, a cross-sectional, 35–40 minute on-line survey that assessed 
the self-reported health behaviors and health status of arthritis patients. Eligible participants 
had a self-reported doctor-diagnosis of arthritis, were at least 18 years of age, could read and 
write in English, had Internet access, and were currently taking at least one medication to 
treat their arthritis on a routine basis. All participants were informed of a $10 incentive prior 
to answering eligibility questions and agreed to participate after reading a study fact sheet. 
The INFORM study was approved by the University of North Carolina’s Institutional 
Review Board.
Recruitment methods have been described in detail elsewhere (Carpenter et al., 2014). 
Briefly, recruitment mailings were sent to persons having a diagnosis of osteoarthritis or 
rheumatoid arthritis according to University of North Carolina Hospital System records and 
general recruitment announcements were distributed via patient websites, local clinics, 
arthritis support groups, and in local media publications and advertising outlets. A total of 
424 patients accessed the study survey between May 2010 and January 2011. Among those, 
71 individuals were ineligible (34 did not meet eligibility criteria; 7 were missing screeners; 
30 surveys were incomplete or duplicate); and 25 declined to participate after reading the 
fact sheet. Three hundred twenty eight patients completed the study survey; 124 were 
recruited from the hospital mailing and 204 from general announcements. We were unable to 
calculate a response rate because the number of arthritis patients who were exposed to the 
general announcements and advertisements was not known.
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Measures
Receipt of medication information was obtained by asking how much medicine information 
they receive (either solicited or unsolicited) when they are prescribed a new arthritis 
medicine from the following fifteen different information sources: physicians, pharmacists, 
nurses, brochures and pamphlets, medicine package inserts, articles and books, newsletters, 
Internet (information websites), support groups (online or in-person), spouse/partner, family 
members other than their spouse, friends, media sources, commercials or advertisements, 
and podcasts. For each source, patients answered one item about how much medicine 
information they receive, ranging from 1= “none” to 4= “a lot.” Patients’ responses were 
averaged and higher mean scores correspond to obtaining greater amounts of medication 
information across sources. Additionally, the following three medication information source 
categories were created: 1. health professionals (i.e., doctors, pharmacists and nurses); 2. 
media (i.e., internet, media (e.g., TV, radio, videos, and podcasts); 3. interpersonal (i.e., 
support groups, spouse/partner, friends, and family); and, 4. printed material (i.e., brochures, 
medicine package inserts, research articles or books, newsletters).
Demographic Characteristics
Patients reported their age (categorized as 18–44 years, 45–64 years, and ≥65 years), gender 
(male, female), race/ethnicity (American Indian/Alaska Native, Asian, Black, Hispanic or 
Latino, Native Hawaiian/Pacific Islander, White, Other; categorized as Black, White and 
Other), and education level (8th grade or less, some high school but no diploma, high school 
graduate or GED, some college but no degree, associate’s degree, bachelor’s degree, 
postgraduate school or degree (considered as minimum number of years of schooling for 
each education level reported: 8,9,12,13,14,16,18).
Clinical/Patient Characteristics
Diagnosis information was obtained patient reports of their year of arthritis diagnosis, age 
at diagnosis, and doctor-diagnosed arthritis type (OA, RA).
Medication information was obtained using two questions. Patients were asked to report the 
number of different arthritis medicines (including prescription medicines, over-the-counter 
medicines, and creams) they were supposed to use according to their current treatment plan. 
To measure medication adherence, we used one item from the validated Vasculitis Self-
Management Survey (VSMS) (percentage of medication doses taken exactly as directed) 
(response options were 0%–24%, 25%–49%, 50%–74%, 75%–99%, 100%; categorized as 
always adherent (%100) versus not always adherent (<100%) (Thorpe et al., 2007).
Arthritis severity (during the past 4 weeks) was assessed using one item (“Based on how you 
have been feeling during the past 4 weeks, please select the one number that best represents 
how severe you consider your arthritis to be.”); responses ranged from: 1 = not at all severe 
to 10 = extremely severe (categorized as less than moderately severe, moderately severe and 
more than moderately severe).
Satisfaction with doctor support was measured using one item (How satisfied are you with 
the medication-related support provided by your doctor?); responses included: 1 = not at all 
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satisfied; 2 = a little satisfied; 3 = somewhat satisfied; and, 4 = very satisfied and were 
dichotomously considered as “less satisfied” (1, 2) and “more satisfied” (3, 4).
Co-morbidities were patient-reported types of major medical conditions (other than arthritis) 
when asked to, “Please list the other major medical conditions that you have.” Using the 
Functional Comorbidity Index (including first and second stage comorbid conditions) (Groll, 
To, Bombardier, & Wright, 2005), we calculated a comorbidity count for each patient 
(ranging from 0 to 25).
Medication self-efficacy was determined by using the 7-item difficulty subscale from the 
Self-Efficacy for Appropriate Medication Use Scale (SEAMS) to measure medication 
adherence self-efficacy (Risser, Jacobson, & Kripalani, 2007). Respondents rated their level 
of confidence in their ability to take medications correctly in a number of difficult situations, 
including when they have a busy day planned, are away from home, or have multiple 
medications to take. The original response scale was modified from three points to five to 
capture greater variability. The modified scale ranged from “not at all confident” (coded as 
1) to “very confident” (coded as 5). We created a summary score by averaging item 
responses. Higher scores represent greater levels of adherence self-efficacy (range 1–5). The 
internal consistency reliability for this sample was high (Cronbach's alpha = 0.91).
Arthritis medication-taking concerns were determined from respondents indicating how 
much of the time they are concerned about the following 6 aspects related to taking a new 
arthritis medicine: 1. taking medicines incorrectly; 2. Interactions with other medicines; 3. 
long-term effects of medicines; 4. financial costs; 5. side effects; and 6. medicines not 
working on a five-point Likert-type scale, ranging from 1 = none of the time to 5 = all of the 
time. Scores obtained for the individual items were summed to give a scale score. Higher 
scores indicate more concern about taking arthritis medicine.
Statistical analysis
Analyses were conducted using SAS software, version 9.3 (SAS Institute, Cary, NC). 
Simple descriptive statistics (frequencies and percentages for categorical variables, means ± 
standard deviations (SD) for continuous variables) were used to summarize sample 
demographic and clinical/patient characteristics. Demographic (i.e., age, gender, race/
ethnicity, education) and clinical/patient (i.e., arthritis type, number of medications, 
medication adherence, arthritis severity, arthritis duration, satisfaction with doctor support, 
comorbidities, medication self-efficacy, arthritis medication taking concerns) variables were 
evaluated using bivariate analyses for their association with receipt of medication 
information using Student’s t-tests, ANOVA and Pearson’s correlation coefficients, as 
appropriate. Any variables significantly (p≤0.05) associated with receipt of medication 
information were then included as explanatory variables in a multivariable linear regression 
model using receipt of medication information as the continuous outcome variable. Linear 
regression analyses were also performed considering OA and RA separately to test which 
clinical/patient characteristics may be associated with receipt of greater amounts of 
medication information. All statistical tests were 2-tailed with α=0.05. Linear regression 
was run in a forward stepwise method based on the Wald's test predicting receipt of arthritis 
medication information.
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Results
The demographic and clinical/patient characteristics of study participants are shown in Table 
1.
Patients' receipt of medication information from specific sources and amount
A total of 324 (99%) participants reported receiving medication related information from at 
least one source when they are prescribed a new arthritis medicine. Of these patients, most 
reported receiving information from physicians (M 3.30; SD .82), followed by medication 
package inserts, (M=2.70, SD=1.04), the Internet (M=2.66, SD=1.07), and brochures 
(M=2.49, SD=1.03); the least amount of information was received through podcasts 
(M=1.12, SD=0.46) followed by support groups (M=1.35, SD=0.77).
The average amount of medication information patients received when prescribed a new 
arthritis medication by source category was the following: 2.52 (SD=.73) from health 
professionals, 1.9 (SD=.64) from media sources, 1.62 (SD=.63) from interpersonal sources, 
and 2.26 (SD=.73) from printed material. All between-group differences were statistically 
significant at p<0.001 (receiving more information from health professional versus media 
sources (t(324)=12.83); health professional versus interpersonal sources (t(321)= 21.57); 
health professional versus printed material (t(323)=6.29); media versus interpersonal sources 
(t(321)= 8.53); printed material versus media sources (t(323)=9.63); and printed material 
versus interpersonal sources (t(321)=15.91)).
Two percent (8/327) of patients indicated that they did not receive any information from 
health professionals, 12% (38/324) from media sources, 28% (89/322) from interpersonal 
sources and 8% (25/324) from printed material. Patients reported not receiving any 
medication related information from a pharmacist or nurse, 33% and 49% of the time, 
respectively.
Bivariate Analyses: variables associated with receipt of arthritis medication information
Greater receipt of information was associated with moderate arthritis severity compared to 
lower than moderate severity, rheumatoid arthritis compared to osteoarthritis, Black race 
compared to White and Other race, more years of schooling, greater number of medications 
taken, more satisfaction with doctor medication-related support, always adherent compared 
to not always adherent, more medication-taking concerns, and having a comorbid 
condition(s) compared to having no comorbidity (Table 2).
Multivariate Analysis: variables associated with receipt of arthritis medication information
In multivariate analysis (Table 3) that examined RA and OA patients together in a single 
sample, of the variables that had significant bivariate associations with medication 
information receipt, the following independent variables remained statistically significant: 
always adherent compared to not always adherent, greater number of medications taken, 
more medicine-taking concerns, more satisfaction with doctor medication-related support, 
and Black race. These variables together explained 21.1% of the variance of medication 
information-receipt (R2 = .21; P < .0001).
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Table 3 also displays results examining information seeking for OA and RA patients 
separately. When considering OA, of the variables that had significant bivariate associations 
with more medication information receipt, the following independent variables remained 
statistically significant in a linear regression: greater number of medications taken, greater 
years of schooling, and more satisfaction with doctor medication-related support. When 
considering RA, of the variables that had significant bivariate associations with more 
medication information receipt, the following independent variables remained statistically 
significant: Black race and greater number of medications taken.
Discussion
To our knowledge, this is the first study to examine whether demographic and clinical/
patient factors are associated with arthritis patients’ receipt of medication information. 
Previous studies have mostly explored predictors of health information seeking, in general, 
rather than receipt of medication related information specifically, analyzed single 
information sources such as the Internet rather than considering multiple sources influencing 
information receipt, and considered information seeking behavior rather than information 
receipt which takes both solicited and unsolicited health information into account. Our 
results add to the health information literature by showing specific differences, across 
individuals with arthritis, OA and RA associated with their receipt of medication 
information. Patient characteristics, the nature of the medication therapy and also the doctor-
patient relationship were all found to be associated with the amount of information patients 
with arthritis report receiving. Findings for OA and RA deepen our understanding of 
condition specific factors associated with receipt of medication-related information. In 
addition, the findings quantify the amount of information received and describe the sources 
through which arthritis patients are receiving medication related information.
While one patient reported not receiving any information from any source, the 
overwhelming majority of patients in this sample reported receiving medication related 
information from at least one source when they are prescribed a new arthritis medicine. In 
agreement with previous studies, we found patients received medication information from 
various sources and reported receiving more information from health professionals 
compared to media, interpersonal and print sources (Carter et al., 2013b; Shieh, McDaniel, 
& Ke, 2009). Next in line after doctors among the individual sources from which patients 
received arthritis medication information was medication package inserts followed by the 
internet. This finding was not surprising, considering the more accessible the information 
source, the more likely one is to use that source (O'Reilly, 1982) and the majority of 
rheumatology patients research their conditions online around the time of doctors’ 
appointments (Hay et al., 2008). Further, patients may be reporting less information receipt 
from traditional media sources (e.g., TV and radio) as direct-to-consumer pharmaceutical 
advertising is shifting into online promotion (e.g., search engine marketing and product Web 
sites) (Ventola, 2011).
Our study provides evidence of important correlates of information receipt which have not 
been considered in other arthritis studies. We found that patients who report being 100% 
adherent to medications received greater amounts of medication related information 
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compared to patients who reported being less adherent. This finding is not supported by 
another study that found nonadherent patients [inflammatory bowel disease] were 2.4 times 
more likely to be active information seekers compared to adherent patients (Pittet et al., 
2014). In our study, information receipt included solicited (e.g., seeking information) and 
unsolicited (e.g., being given information) medication-related information from 15 sources 
whereas, the previously described study considered only active information seeking from 6 
sources. This is an important distinction because studies assessing information seeking 
would only include information from health professionals, for example, if the patient 
specifically requested information or asked questions about certain medications (Barsevick 
& Johnson, 1990). A more inclusive consideration of solicited and unsolicited receipt of 
information from a larger number of sources likely provides a better approximation of the 
amount of information patients receive than using information seeking behavior alone and 
fewer sources. More research is needed to understand the mechanisms through which receipt 
of medication information (i.e., passive versus active receipt) may influence health behaviors 
such as medication adherence.
The more medications patients in our sample were taking, the more arthritis medication 
information they reported receiving. When considered seprately, this finding also held for 
RA patients and OA patients. Different from our findings, one study found that the degree of 
information seeking did not vary by reported number of drugs taken (DeLorme et al., 2011). 
Here too, DeLorme et al. assessed information seeking rather than information receipt and 
different methodological measures makes comparison across studies difficult. There is a 
need for the development of working outcome definitions that could be used and compared 
in studies conducted across disciplines. A better understanding of number of arthritis 
medications taken and information receipt has important implications for arthritis patients’ 
information needs such as helping patients receive consistent high quality medication 
information and navigating issues associated with reliable source use and receipt of 
conflicting medication information.
Our results related to medication taking concerns are in line with theory suggesting that 
disease related anxiety may play a role in information receipt, and current research findings 
related to patient worry and sensitivities around medication taking. Health information 
seeking has been described as a coping behavior to reduce an individual’s stress and worry 
associated with uncertainty (Lambert & Loiselle, 2007). Research shows that patients who 
believe they are highly sensitive to medicines (e.g., more likely to experience medication 
side effects) are more likely to seek information about medicines (Carter et al., 2013b). High 
medication seeking from all sources has also been found to be related to worry about the 
health consequences of taking medication, particularly among those with a recent 
medication change (Carter et al., 2013b). It is likely that greater patient worry increases the 
belief that the information provided will be relevant and help them manage their medicines 
(Carter, Moles, White, & Chen, 2013a).
Patients in this sample who were more satisfied with doctor medication-related support 
received more arthritis medication information. This finding is in line with research showing 
higher quality physician-patient relationships can increase or encourage discussion about 
disease management and treatment options (Beach, Roter, Wang, Duggan, & Cooper, 2006). 
Geryk et al. Page 9
J Health Commun. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A review of doctor-patient communication found greater patient satisfaction with a medical 
visit was associated with more information provided by the doctor and longer appointment 
times (L. Ong, De Haes, Hoos, & Lammes, 1995). When considering OA and RA separately, 
we were surprised that doctor support was associated with receiving more medication 
information for OA patients but not RA patients because RA patients have more frequent 
office visits compared to OA patients (Lanes et al., 1997).
Our finding that Black race compared to White race is associated with more medication 
information seeking for arthritis patients (and RA patients) was not expected. Research 
findings are mixed, with one study suggesting that whites seek more health information 
compared to Blacks (Laz & Berenson, 2013) while other findings show no differences in 
race related to information seeking behaviors (Cotten & Gupta, 2004). Our findings may 
reflect research showing that race has not been found to be associated with receiving 
arthritis-specific care or prescription arthritis medicines (Mikuls, Mudano, Pulley, & Saag, 
2003) and that among online adults, evidence of a digital divide no longer exists, with blacks 
going online on mobile devices more frequently than whites (Kontos, Blake, Chou, & 
Prestin, 2014; Smith, 2012). Additionally, considering findings from one study showing that 
among osteoarthritis patients, Black patients were less likely than white patients to report a 
good understanding of joint replacement as a form of treatment, it may be that RA is a less 
well known condition among Black patients compared to other races (Ibrahim, Siminoff, 
Burant, & Kwoh, 2002).
Almost one third of patients in this sample reported not receiving any medication 
information from interpersonal sources, including spouse, family, and friends. It seems 
expected that during a time when patients are likely to experience specific information needs 
related to being prescribed a new arthritis medication, they would tend to receive 
information from clinical or media sources more than interpersonal sources. This is likely 
because health professionals generally provide factual information, while lay sources 
provide both factual and emotional information (Kjos, Worley, & Schommer, 2011).
We found an inverse association for patients with OA between less years of schooling and 
greater receipt of medication information, which is consistent with previous studies 
associating higher education levels with more information seeking (Bundorf et al., 2006; 
Kontos et al., 2014; Lustria et al., 2011). The mechanisms are surely multifactorial but 
partially may be attributable to education acting as a proxy for greater expected benefits of 
health information (Bundorf et al., 2006) and issues of health literacy and eHealth literacy 
(Kontos et al., 2014). Limitations
While this study has identified important and some potentially modifiable patient/clinical 
characteristics (e.g., increased adherence and more medication taking concerns) that are 
associated with patients receiving more medication information, we cannot determine 
whether the explanatory variables in our regression models were a cause or consequence of 
greater patient receipt of information. Longitudinal follow-up studies will be required to 
determine whether demographic and patient/clinical characteristics predict more information 
receipt in arthritis patients.
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It is also possible that patients with severely disabling RA or OA, those with mild OA, those 
without internet access or computer literacy skills were underrepresented in our online 
survey sample, which impedes our ability to generalize the results to larger population of 
OA and RA patients. Further, our low response rate for mailed recruitment efforts represents 
a selection bias and our sample was largely White, college-educated and female, which 
further limits the study’s generalizability. In addition, we were not able to assess 
demographic differences between those who responded to the survey and those who did not.
As with any survey, there is the potential for bias in self-reports; not verified through clinical 
records or other assessment. However, self-reported medical information for chronic 
diseases has been shown to have good sensitivity and specificity compared to patient 
medical record information (Fowles, Fowler, & Craft, 1998). Finally, though our regression 
model was significant, it only explained a small amount of variance in medication related 
information-receipt. This could be due to measurement error, but may also reflect the fact 
that additional and multiple intrapersonal, interpersonal, and macro level factors are involved 
in explaining additional variance.
Conclusion and Implications
Arthritis patients in this sample took an average of two arthritis medications and received 
more medication information from professional and media source than print and 
interpersonal sources. Both positive (e.g., increased adherence, greater satisfaction with 
doctor medication-related support, and negative (more medication taking concerns) clinical/
patient characteristics were associated with receiving more medication information. In the 
clinic setting, it may be valuable for doctors to devote time to talking with patients about 
aspects of medication related information through the lens of information sources with the 
goal in mind of providing high quality resource options to help increase patient knowledge, 
reduce anxiety, and improve medication adherence. Public health efforts related to 
medication education for arthritis patients should focus on professional and media source 
delivery.
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Table 1
Sample characteristics (N=328)
N (%)
Gender
 Male 68 (21)
 Female 260 (79)
Race
 White 263 (80)
 African American 45 (14)
 Other 20 (6)
Age group (years)
 18–44 years 50 (15)
 45–64 years 192 (59)
 ≥ 65 years 86 (26)
Education level
 ≤ High school diploma 50 (15)
 At least some college 114 (35)
 Completed college or greater 164 (50)
Arthritis type
 Osteoarthritis 149 (48)
 Rheumatoid arthritis 159 (52)
Arthritis duration (years)
 < 6 years 117 (36)
 6–19 years 158 (48)
 ≥ 20 years 53 (16)
Arthritis severity
 Less than moderate 106 (32)
 Moderate 94 (29)
 Greater than moderate 127 (39)
Arthritis medication(s)
 ≤ 1 medication 83 (26)
 2 medications 113 (35)
 ≥ medications 129 (39)
Comorbid conditions
 Yes 159 (49)
 No 168 (51)
Medication adherence
 Always adherent 163 (50)
 Less than always adherent 160 (50)
Satisfaction with doctor support
 More satisfied 266 (84)
 Less satisfied 52 (16)
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Values represent numbers of patients (percentage).
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Table 2
Bivariate analyses: variables associated with receipt of arthritis medication information
Correlation with receipt of medication information score
r (n) p-value
Number of Medications 0.27 (286) <.0001
Years of education −0.19 (288) 0.001
Medication taking concerns score 0.21 (280) 0.004
Mean receipt of medication information score per category
Mean ± SD (n) p-value
Race 0.0008
 White 2.02 ± .50 (262)
 African American 2.33 ± .65 (45)
 Other 1.94 ± .39 (20)
Arthritis type 0.0013
 Osteoarthritis 1.96 (149)
 Rheumatoid arthritis 2.16 (158)
Arthritis severity 0.04
 Less than moderate 1.95 (105)
 Moderate 2.17 (94)
 Greater than moderate 2.08 (127)
Satisfaction with doctor support 0.01
 More satisfied 2.09 ± .50 (234)
 Less satisfied 1.86 ± .51 (46)
Medication adherence 0.01
 Always adherent 2.1 ± .54 (145)
 Less than always adherent 1.9 ± .46 (140)
Comorbid condition 0.03
 Yes 2.1 ± .55 (155)
 No 1.9 ± (164)
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